IL 28A Human, His

Interleukin-28A Human Recombinant, His Tag
Cat. No.
BT3229
Source
Escherichia Coli.
Synonyms
Interleukin-28A, IL-28A, IFN-Lambda 2, Interferon-Lambda 2, Cytokine ZCYTO20, IL28A, IFNL2, ZCYTO20.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 85% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

IL 28A Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 198 amino acids (26-200 a.a.) and having a molecular mass of 22.1kDa. IL 28A is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
IL-28A, a cytokine distantly related to type I interferons and the IL-10 family, is induced by viral infections. It binds to a heterodimeric receptor composed of IL10RB and IL28RA, triggering antiviral, antiproliferative, and antitumor activities. While sharing similarities with type I IFNs, IL-28A exhibits a narrower range of activity and is generally less potent. Notably, IFN-lambda 1, IFN-lambda 2, and IFN-lambda 3 genes cluster on human chromosome 19. IL-28A uniquely induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, independent of IFN-gamma. Interestingly, IL-28A can generate tolerogenic dendritic cells, potentially counteracting IFN-beta functions. Upon viral infection, IL-28A activates monocytes and macrophages, inducing a specific set of cytokines and playing a crucial role in initiating innate immune responses at the infection site.
Description
Recombinant human IL-28A, expressed in E. coli, is a non-glycosylated polypeptide chain comprising 198 amino acids (residues 26-200). It possesses a molecular weight of 22.1 kDa and includes a 23 amino acid His-tag at the N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The IL-28A protein solution is supplied at a concentration of 0.5 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 10% glycerol, and 0.4 M Urea.
Stability
For short-term storage (up to 4 weeks), the IL-28A solution should be stored at 4°C. For extended storage, it is recommended to store the solution frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing of the solution should be avoided.
Purity
The purity of IL-28A is determined to be greater than 85% by SDS-PAGE analysis.
Synonyms
Interleukin-28A, IL-28A, IFN-Lambda 2, Interferon-Lambda 2, Cytokine ZCYTO20, IL28A, IFNL2, ZCYTO20.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSVPVARLH GALPDARGCH IAQFKSLSPQ ELQAFKRAKD ALEESLLLKD CRCHSRLFPR TWDLRQLQVR ERPMALEAEL ALTLKVLEAT ADTDPALVDV LDQPLHTLHH ILSQFRACIQ PQPTAGPRTR GRLHHWLYRL QEAPKKESPG CLEASVTFNL FRLLTRDLNC VASGDLCV .

Product Science Overview

Structure and Production

IL-28A is produced as a recombinant protein in Escherichia coli (E. coli). The recombinant form is a single, non-glycosylated polypeptide chain consisting of 198 amino acids (26-200 a.a.) and has a molecular mass of approximately 22.1 kDa . This protein is fused to a 23 amino acid His-tag at the N-terminus, which facilitates its purification through affinity chromatography .

Biological Function

IL-28A plays a crucial role in the innate immune response to viral infections. It is known to induce the expression of antiviral proteins and has antiproliferative and antitumor activities . IL-28A interacts with a heterodimeric class II cytokine receptor composed of the interleukin-10 receptor, beta (IL10RB), and the interleukin-28 receptor, alpha (IL28RA) .

Mechanism of Action

Upon viral infection, IL-28A is produced and activates both monocytes and macrophages, leading to the production of a restricted panel of cytokines . This activation is crucial for initiating and sustaining the antiviral state in infected cells. IL-28A also induces the expression of ELR (-) CXC chemokine mRNA in human peripheral blood mononuclear cells, independent of IFN-gamma .

Applications

Recombinant IL-28A is used extensively in laboratory research to study its role in the immune response and its potential therapeutic applications. It is important to note that this product is intended for research use only and is not suitable for use as a drug, agricultural or pesticidal product, food additive, or household chemical .

Storage and Stability

The recombinant IL-28A protein is typically supplied as a sterile, filtered, colorless solution. It is formulated in a buffer containing 20 mM Tris-HCl (pH 8.0), 10% glycerol, and 0.4 M urea . For short-term storage, it should be kept at 4°C if used within 2-4 weeks. For long-term storage, it is recommended to store the protein at -20°C and to add a carrier protein (0.1% HSA or BSA) to prevent degradation . Multiple freeze-thaw cycles should be avoided to maintain protein integrity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.